New hope for advanced cervical cancer: drug combo trial launches
Disease control
Not yet recruiting
This Phase 3 trial tests whether a combination of two drugs, WX390 and toripalimab, can help people with recurrent or metastatic cervical cancer that has not responded to platinum-based chemotherapy. About 440 participants will be randomly assigned to receive either the new combi…
Phase: PHASE3 • Sponsor: Shanghai Jiatan Pharmatech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC